Also known as Bepecin, BPC 157, Body Protection Compound 157, Pentadecapeptide BPC-157, PCO-02 Evidence records Studies, registries, reviews, and regulatory records Registered human trials NCT02637284 is a Phase 1 oral safety and pharmacokinetics study in healthy volunteers
Consequently, a small molecule was developed to inhibit the interaction between NF-B and IKK
The choice depends on your skin type, concerns, and health goals
BPC-157 C62H98N16O22 Estimated delivery: Thu, Aug 6 Mon, Aug 10 Order within 19 hrs 12 mins for same-day shipping Quality Tested 3rd party verified Support Fast Shipping Priority same-day About This Compound To reconstitute properly, add bacteriostatic water slowly along the wall of the vial
TB-500 and GHK-Cu have favorable preclinical safety data but lack human safety studies
PMID 36883831